Twist Bioscience (TWST)
(Real Time Quote from BATS)
$47.44 USD
-0.55 (-1.15%)
Updated Sep 20, 2024 09:48 AM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Average Brokerage Rating
Current ABR | 1.60 |
ABR (Last week) | 1.60 |
# of Recs in ABR | 10 |
Average Target Price | $50.22 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 85 of 253 |
Current Quarter EPS Est: | -0.73 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.60 | 1.60 | 1.60 | 1.60 | 1.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/5/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
8/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/2/2024 | William Blair | Matt Larew | Strong Buy | Strong Buy |
8/2/2024 | SVB Securities | Puneet Souda | Hold | Hold |
7/9/2024 | Goldman Sachs | Matthew Sykes | Strong Buy | Strong Buy |
6/4/2024 | Guggenheim Securities | Subbu Nambi | Not Available | Strong Buy |
5/7/2024 | Scotiabank | Sung-Ji Nam | Strong Buy | Strong Buy |
5/3/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.